Blood Doping: Risks to Athletes’ Health and Strategies for Detection

REFERENCES

• Arndt, P. A., & Kumpel, B. M. (2008). Blood doping in athletes-detection of allogeneic blood transfusions by flow cytofluorometry. American Journal of Hematology, 83(8), 657–667.
   PubMed Web of Science ®Google Scholar
• Ashenden, M., Varlet-Marie, E., Lasne, F., & Audran, M. (2006). The effects of microdose recombinant human erythropoietin regimens in athletes. Haematologica, 91, 1143–1144.
   PubMed Web of Science ®Google Scholar
• Azzazy, H. M. E. (2010). Gene Doping. In: D. Thieme & P. Hemmersbach (eds.), Doping in sports (pp. 487–509). Heidelberg: Springer.
   Google Scholar
• Banfi, G. (2011). Limits and pitfalls of Athlete's Biological Passport. Clinical Chemistry and Laboratory Medicine, 49(9), 1417–1421.
   PubMed Web of Science ®Google Scholar
• Baoutina, A., Alexander, I. E., Rasko, J. E., & Emslie, K. R. (2008). Developing strategies for detection of gene doping. The Journal of Gene Medicine, 10, 3–20.
   PubMed Web of Science ®Google Scholar
• Baoutina, A., Coldham, T., Bains, G. S., & Emslie, K. R. (2010). Gene doping detection: Evaluation of approach for direct detection of gene transfer using erythropoietin as a model system. Gene Therapy, 17, 1022–1032.
   PubMed Web of Science ®Google Scholar
• Beiter, T., Zimmermann, M., Fragasso, A., Hudemann, J., Niess, A. M., Bitzer, M., … Simon P. (2011). Direct and long-term detection of gene doping in conventional blood samples. Gene Theraphy, 18(3), 225–231.
   PubMed Web of Science ®Google Scholar
• Bento, R. M. A., Damasceno, L. M. P., & Aquino Neto, F. R. (2003). Eritropoetina recombinante humana no esporte: Uma Revisão. Revista Brasileira de Medicina do Esporte, 9, 169–180.
   Google Scholar
• Bernardi, L., Passino, C., Spadacini, G., Bonfichi, M., Arcaini, L., Malcovati, L., … Bernasconi, C. (2007). Reduced hypoxic ventilatory response with preserved blood oxygenation in yoga trainees and Himalayan Buddhist monks at altitude: Evidence of a different adaptive strategy? European Journal of Applied Physiology, 99, 511–518.
   PubMed Web of Science ®Google Scholar
• Beuck, S., Bornatsch, W., Lagojda, A., Schänzer, W., & Thevis, M. (2011). Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research. Drug Testing and Analysis, 3(11–12), 756–70.
   Web of Science ®Google Scholar
• Beullens, M., Delanghe, J. R., & Bollen, M. (2006). False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise. Blood, 107, 4711–4713.
   PubMed Web of Science ®Google Scholar
• Bunn, H. F. (2007). New agents that stimulate erythropoiesis. Blood, 109(3), 868–873.
   PubMed Web of Science ®Google Scholar
• Chenuaud, P., Larcher, T., Rabinowitz, J. E., Provost, N., Cherel, Y., Casadevall, N., … Moullier, P. (2004). Autoimmune anemia in macaques following erythropoietin gene therapy. Blood, 103, 3303–3304.
   PubMed Web of Science ®Google Scholar
• Cazzola, M. (2000). A global strategy for prevention and detection of blood doping with erythropoietin and related drugs. Haematologica, 85, 561–563.
   PubMed Web of Science ®Google Scholar
• Delanghe, J. R., & Joyner, M. J. (2008). Testing for recombinant human erythropoietin. Journal of Applied Physiology, 105(2), 395–396
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis, E., Konstantinopoulos, P. A., Papailiou, J., Kandarakis, S. A., Andreopoulos, A., & Sykiotis, G. P. (2005). Erythropoietin abuse and erythropoieitin gene doping: Detection strategies in the genomic era. Sports Medicine, 35, 831–840.
   PubMed Web of Science ®Google Scholar
• Egrie, J. C., & Browne, J. K. (2001). Development and characterization of novel erythropoiesis stimulating protein (NESP). Nephrology, Dialysis and Transplantation, 16, 3–13.
   PubMed Web of Science ®Google Scholar
• Eichner, E. R. (2007). Blood doping infusions, erythropoietin and artificial blood. Sports Medicine, 37(4–5), 389–391.
   PubMed Web of Science ®Google Scholar
• Ekblom, B., Goldbarg, A. N., & Gullbring, B. (1972). Response to exercise after blood loss and reinfusion. Journal of Applied Physiology, 33, 175–180.
   PubMed Web of Science ®Google Scholar
• Ekblom, B., Wilson, G., & Astrand, P. O. (1976). Central circulation during exercise after venesection and reinfusion of red blood cells. Journal of Applied Physiology, 40, 379–383.
   PubMed Web of Science ®Google Scholar
• Elliot, S. (2008). Erythropoieisis-stimulanting agents and other methods to enhance oxygen transport. British Journal of Pharmacology, 154, 529–541.
   PubMed Web of Science ®Google Scholar
• Franz, S. E. (2009). Erythropoiesis-stimulating agents: Development, detection and dangers. Drug Testing and Analysis, 1, 245–249.
   PubMed Web of Science ®Google Scholar
• Gao, G., Lebherz, C., Weiner, D. J., Grant, R., Calcedo, R., McCullough, B., … Wilson, J. M. (2004). Erythropoietin gene therapy leads to autoimmune anemia in macaques. Blood, 103(9), 3300–3302.
   PubMed Web of Science ®Google Scholar
• Giménez, E., Ramos-Hernan, R., Benavente, F., Barbosa, J., & Sanz-Nebot, V. (2012). Analysis of recombinant human erythropoietin glycopeptides by capillary electrophoresis electrospray-time of flight-mass spectrometry. Analytical Chimica Acta, 709, 81–90.
   PubMed Web of Science ®Google Scholar
• Giraud, S., Sottas, P. E., Robinson, N., & Saugy, M. (2010). Blood Transfusion in Sports. In: D. Thieme, & P. Hemmersbach (eds.), Doping in sports (pp. 295–304). Heidelberg: Springer.
   Google Scholar
• Glaspy, J. A. (2003). Hematopoietic management in oncology practice. Part 2. Erythropoietic factors. Oncology, 17, 1724–1730.
   PubMedGoogle Scholar
• Gore, C., Parisotto, R., Ashenden, M., Stray-Gundersen, J., Sharpe, K., Hopkins, W., … Hahn, A. G. (2003). Second-generation blood tests to detect erythropoietin abuse by athletes. Haematologica, 88, 333–344.
   PubMed Web of Science ®Google Scholar
• Guan, F., Uboh, C. E., Soma, L. R., Birksz, E., Chen, J., You, Y., … Li, X. (2008). Differentiation and identification of recombinant human erythropoietin and darbepoetin alfa in equine plasma by LC-MS/MS for doping control. Analytical Chemistry, 80, 3811–3817.
   PubMed Web of Science ®Google Scholar
• Guan, F., Uboh, C. E., Soma, L. R., Birksz, E., & Chen J. (2009). Identification of darbepoetin alfa in human plasma by liquid chromatography coupled to mass spectrometry for doping control. International Journal of Sports Medicine, 30, 80–86.
   PubMed Web of Science ®Google Scholar
• Harrison, C. R., & Vydha, S. (2012). Capillary electrophoretic analysis of whole blood samples for hemoglobin-based oxygen carriers without the use of immunoprecipitation. Electrophoresis, 33(7), 1087–1094.
   PubMed Web of Science ®Google Scholar
• Howman, D. (2012). Current limitations in analytical strategies. Bioanalysis, 4, 1535–1536.
   PubMed Web of Science ®Google Scholar
• Jelkmann, W. (2008a). Developments in the therapeutic use of erythropoiesis stimulating agents. British Journal of Haematology, 141(3), 287–297.
   PubMed Web of Science ®Google Scholar
• Jelkmann, W. (2008b). Testing for recombinant human erythropoietin. Journal of Applied Physiology, 105(6), 1992, author repply 1997–1998.
   PubMed Web of Science ®Google Scholar
• Jelkmann, W., & Lundby, C. (2011). Blood doping and its detection. Blood, 118, 2395–2404.
   PubMed Web of Science ®Google Scholar
• John, M. J., Jaison, V., Jain, K., Nakkar, N., & Jacob, J. J. (2012). Erythropoietin use and abuse. Indian Journal of Endocrinology and Metabolism, 16, 220–227.
   PubMedGoogle Scholar
• Jones, M., & Pedoe, D. S. T. (1989). Blood doping –a literature review. British Association of Sports and Medicine, 23(2), 84–88.
   PubMedGoogle Scholar
• Kayser, B. (2008). Testing for recombinant human erythropoietin. Journal of Applied Physiology, 105(6), 1993, author repply 1997–1998.
   PubMed Web of Science ®Google Scholar
• Kohler, M., Ayotte, C., Desharnais, P., Flenker, U., Lüdke, S., Thevis, M., … Schänzer, W. (2007). Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels. International Journal Sports Medicine, 29, 1–6.
   PubMed Web of Science ®Google Scholar
• Lacombe, C., & Mayeux, P. (1998). Biology of Erythropoietin. Haematologica, 83, 724–732.
   PubMed Web of Science ®Google Scholar
• Lamon, S., Giraud, S., Egli, L., Smolander, J., Jarsch, M., Stubenrauch, K. G., … Robinson, N. (2009). A high-throughput test to detect C. E. R. A. doping in blood. Journal of Pharmaceutical and Biomedical Analysis, 50, 954–958.
   PubMed Web of Science ®Google Scholar
• Lamon, S., Robinson, N., Sottas, P. E., Henry H., Kamber, M., Mangin, P., … Saugy, M. (2007). Possible origins of undetectable EPO in urine samples. Clinica Chimica Acta, 385, 61–66.
   PubMed Web of Science ®Google Scholar
• Lasne, F. (2008). Testing for recombinant human erythropoietin. Journal of Applied Physiology, 105(6), 1993–1994, author repply 1997–1998.
   PubMed Web of Science ®Google Scholar
• Lasne, F., Crepin, N., Ashenden, M., Audran, M., & De Ceaurriz, J. (2004a). Detection of hemoglobin-based oxygen carriers in human serum for doping analysis: screening by electrophoresis. Clinical Chemistry, 50, 410–415.
   PubMed Web of Science ®Google Scholar
• Lasne, F., & de Ceaurriz, J. (2000). Recombinant erythropoietin in urine. Nature, 405, 635.
   PubMed Web of Science ®Google Scholar
• Lasne, F., Martin, L., Crepin, N., & de Ceaurriz, J. (2002). Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones. Analytical Biochemistry, 311, 119–126.
   PubMed Web of Science ®Google Scholar
• Lasne, F., Martin, L., De Ceaurriz, J., Larcher, T., Moullier, P., & Chenuaud, P. (2004b). ‘‘Genetic Doping’’ with erythropoietin cDNA in primate muscle is detectable. Molecular Therapy, 10, 409–410.
   PubMed Web of Science ®Google Scholar
• Lee, J. S., Ha, T. K., Lee, S. J., & Lee, G. M. (2012). Current state and perspectives on erythropoietin production. Applied Microbiology and Biotechnology, 95, 1405–1416.
   PubMed Web of Science ®Google Scholar
• Leigh-Smith, S. (2004). Blood boosting. British Association of Sports and Medicine, 38, 99–101.
   PubMed Web of Science ®Google Scholar
• Leuenberger, N., Reichel, C., & Lasne, F. (2012). Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future. Bioanalysis, 4, 1565–1575.
   PubMed Web of Science ®Google Scholar
• Leuenberger, N., Saugy, J., Mortensen, R. B., Schatz, P. J., Giraud, S., & Saugy, M. (2011). Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples. Forensic Science International, 213, 15–19.
   PubMed Web of Science ®Google Scholar
• Lin, F. K., Suggs, S., Lin, C. H., Browne, J. K., Smalling, R., Egrie, J. C., … Stabinsky, Z. (1985). Cloning and expression of the human erythropoietin gene. Procedding of the National Academy of Sciences of the United States of America, 82, 7580–7584.
   PubMed Web of Science ®Google Scholar
• Lippi, G. (2008). Testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing. Anti-doping testing: friend or foe? Journal of Applied Physiology, 105(6), 1992, author repply 1997–1998, author repply 1997–1998.
   PubMed Web of Science ®Google Scholar
• Lippi, G., & Banfi, G. (2006b). Blood transfusions in athletes. Old dogmas, new tricks. Clinical Chemistry and Laboratory Medicine, 44, 1395–1402.
   PubMed Web of Science ®Google Scholar
• Lippi, G., Franchini, M., Salvagno, G. L., & Guidi, C. (2006a). Biochemistry, physiology, and complications of blood doping: Facts and Speculation. Critical Reviews in Clinical Laboratory Sciences, 43(4), 349–391.
   PubMed Web of Science ®Google Scholar
• Lippin, Y., Dranitzki-Elhalel, M., Brill-Almon, E., Mei-Zahav, C., Mizrachi, S., Liberman, Y., … Galun, E. (2005). Human erythropoietin gene therapy for patients with chronic renal failure. Blood, 106, 2280–2286.
   PubMed Web of Science ®Google Scholar
• Lombardi, G., Banfi, G., Lippi, G., & Sanchis-Gomar, F. (2013). Ex vivo erythrocyte generation and blood doping. Blood Transfusion, 11(2), 161–163.
   PubMed Web of Science ®Google Scholar
• Lönnberg, M., Andrén, M., Birgegård, G., Drevin, M., Garle, M., & Carlsson, J. (2012). Rapid detection of erythropoiesis-stimulating agents in urine and serum. Analytical Biochemistry, 420, 101–114.
   PubMed Web of Science ®Google Scholar
• Lundby, C., Achman-Andersen, N. J., Thomsen, J. J., Norgaard, A. M., & Robach, P. (2008). Testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing. Journal of Applied Physiology, 105, 417–429.
   PubMed Web of Science ®Google Scholar
• Lundby, C., Robach, P., & Saltin, B. (2012). The evolving science of detection of ‘blood doping’. British Journal of Pharmacology, 165(5), 1306–15.
   PubMed Web of Science ®Google Scholar
• Ma, Z., Monk, T. G., Goodnough, L. T., McClellan, A., Gawryl, M., Clark, T., … Scott, M. G. (1997). Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests. Clinical Chemistry, 43(9), 1732–1737.
   PubMed Web of Science ®Google Scholar
• Marrocco, C., Pallotta, V., D'Alessandro, A., Alves, G., & Zolla, L. (2012). Red blood cell populations and membrane levels of peroxiredoxin 2 as candidate biomarkers to reveal blood doping. Blood Transfusion, 10(Suppl 2), s71–77.
   PubMedGoogle Scholar
• Mazzoni, C., Nugent, L., Klein, D., Hoffman, J., Sekins, K. M., & Flaim, S. F. (1999). Dose monitoring in partial liquid ventilation by infrared measurement of expired perfluorochemicals. Biomedical Instrumentation & Technology, 33, 356–364.
   PubMedGoogle Scholar
• Möller, I., Thomas, A., Geyer, H., Schänzer, W., & Thevis, M. (2011). Synthesis, characterisation and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes. Rapid Communications in Mass Spectrometry, 25(15), 2115–2123.
   PubMed Web of Science ®Google Scholar
• Möller, I., Thomas, A., Delahaut, P., Geyer, H., Schänzer, W., & Thevis, M. (2012). Mass spectrometric detection of peginesatide in human urine in doping control analysis. Journal of Pharmaceutical and Biomedical Analysis, 70, 512–517.
   PubMed Web of Science ®Google Scholar
• Morkeberg, J. (2012). Detection of autologous blood transfusions in athletes: a historical perspective. Transfusion Medicine Reviews, 26(3), 199–208.
   PubMed Web of Science ®Google Scholar
• Morkeberg, J., Belhage, B., & Damsgaard, R. (2008). Testing for recombinant human erythropoietin. Journal of Applied Physiology, 105(6), 1994–1995, author repply 1997–1998.
   PubMed Web of Science ®Google Scholar
• Nett, J. H., Gomathinayagam, S., Hamilton, S. R., Gong, B., Davidson, R. C., Du, M., … Sethuraman, N. (2012). Optimization of erythropoietin production with controlled glycosylation-PEGylated erythropoietin produced in glycoengineered Pichia pastoris. Journal of Biotechnology, 157, 198–206.
   PubMed Web of Science ®Google Scholar
• Oliveira, R. S., Collares, T. F., Smith, K. R., Collares, T. V., & Seixas, F. K. (2011). The use of genes for performance enhancement: doping or therapy? Brazilian Journal of Medical and Biological Research, 44, 1194–1201.
   PubMed Web of Science ®Google Scholar
• Pottgiesser, T., & Schumacher, Y. O. (2012). Biomarker monitoring in sports doping control. Bioanalysis, 4, 1245–1253.
   PubMed Web of Science ®Google Scholar
• Reichel, C. (2011a). Recents developments in doping testing for erythropoietin. Analytical Bioanalytical Chemistry, 401, 463–481.
   PubMed Web of Science ®Google Scholar
• Reichel, C. (2011b). OMICS-strategies and methods in the fight against doping. Forensic Science International, 213(1–3), 20–34.
   PubMed Web of Science ®Google Scholar
• Reichel, C., Abzieher, F., & Geisendorfer, T. (2009a). Sarcosyl-PAGE: a new method for the detection of Mircera- and EPO doping in blood. Drug Test Analysis, 1, 494–504.
   PubMed Web of Science ®Google Scholar
• Reichel, C., & Gmeiner, G. (2010). Erythropoietin and Analogs. In: D. Thieme, & P. Hemmersbach, (Eds.), (Doping in sports (pp. 251–294). Heidelberg: Springer.
   Google Scholar
• Reichel, C., Kulovics, R., Jordan, V., Watzinger, M., & Geisendorfer, T. (2009b). SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control. Drug Testing Analysis, 1, 43–50.
   PubMed Web of Science ®Google Scholar
• Rivera, V. M., Gao, G. P., Grant, R. L., Schnell, M. A., Zoltick, P. W., Rozamus, L. W., … Wilson, J. M. (2005). Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. Blood, 105(4), 1424–1430.
   PubMed Web of Science ®Google Scholar
• Robinson, N., Dollé, G., Garnier, P. Y., & Saugy, M. (2012). 2011 lAAF World Championships in Daegu: blood tests for all athletes in the framework of the Athlete Biological Passport. Bioanalysis, 4(13), 1633–1643.
   PubMed Web of Science ®Google Scholar
• Salvagno, G. L., & Guidi, G. C. (2008). Testing for recombinant human erythropoietin. Journal of Applied Physiology, 105(6), 1992–1993, author repply 1997–1998.
   PubMed Web of Science ®Google Scholar
• Saugy, M., Robinson, N., & Lanon, S. (2008). Testing for recombinant human erythropoietin. Journal of Applied Physiology, 105(6), 1995–1996, author repply 1997–1998.
   PubMed Web of Science ®Google Scholar
• Schänzer, W., & Geyer, H. (2008). Testing for recombinant human erythropoietin. Journal of Applied Physiology, 105(6), 1996, author repply 1997–1998.
   PubMed Web of Science ®Google Scholar
• Schumacher, Y. O., & D'Onofrio G. (2012). Scientific expertise and the Athlete Biological Passport: 3 years of experience. Clinical Chemistry, 58(6) 979–985.
   PubMed Web of Science ®Google Scholar
• Schumacher, Y. O., & Ashenden, M. (2004). Doping with artificial oxygen carriers - An update. Sports Medicine, 34(3), 141–150.
   PubMed Web of Science ®Google Scholar
• Schumacher, Y. O., & Pottgiesser, T. (2008). Testing for recombinant human erythropoietin. Journal of Applied Physiology, 105(6), 1994, author repply 1997–1998.
   PubMed Web of Science ®Google Scholar
• Scott, M. G., Kucik, D. F., Goodnough, L. T., & Monk, T. G. (1997). Blood substitutes: evolution and future applications. Clinical Chemistry, 43(9), 1724–1731.
   PubMed Web of Science ®Google Scholar
• Shaffer, T. H., Foust, R., Wolfson, M. R., & Miller, T. F. (1997). Analysis of perfluorochemical elimination from the respiratory system. Journal of Applied Physiology, 83, 1033–1040.
   PubMed Web of Science ®Google Scholar
• Sharp, N. C. (2010). The human genome and sport, including epigenetics, gene doping, and athleticogenomics. Endocrinology Metabolism Clinics of North America, 39, 201–215.
   PubMed Web of Science ®Google Scholar
• Shin, S. K., Pack, S. P., Oh JG, Kang NK, Chang MH, Chung Y. H., … , Heo, T. H. (2011). Anti-erythropoietin and anti-thrombopoietin antibodies induced after administration of recombinant human erythropoietin. International Immunopharmacology, 11, 2237–2241.
   PubMed Web of Science ®Google Scholar
• Simitsek, P. D., Giannikopoulou, P., Katsoulas, H., Sianos, E., Tsoupras, G., Spyridaki, M.-H., … Georgakopoulos, C. (2007). Electrophoretic, size-exclusion high-performance liquid chromatography and liquid chromatography-electrospray ionization ion trap mass spectrometric detection of hemoglobin-based oxygen carriers. Analytica Chimica Acta, 583, 223–230.
   PubMed Web of Science ®Google Scholar
• Skibeli, V. (2008). Testing for recombinant human erythropoietin. Journal of Applied Physiology, 105(6), 1995, author repply 1997–1998.
   Web of Science ®Google Scholar
• Smalling, R., Foote, M., Molineux, G., Swanson, S. J., & Elliott, S. (2004). Drug-induced and antibody-mediated pure red cell aplasia: A review of literature and current knowledge. Biotechnology Annual Review, 10, 237–250.
   PubMedGoogle Scholar
• Solymos, E., Guddat, S., Geyer, H., Flenker, U., Thomas, A., Segura, J., … Schänzer, W. (2010). Rapid determination of urinary di(2-ethylhexyl) phthalate metabolites based on liquid chromatography/tandem mass spectrometry as a marker for blood transfusion in sports drug testing. Analytical and Bioanalytical Chemistry, 401, 517–528.
   PubMed Web of Science ®Google Scholar
• Sottani, C., Fiorentino, M., & Minoia, C. (1997). Matrix performance in matrix assisted laser desorption/ionization for molecular weight determination in sialyl and non-sialyl oligosaccharide proteins. Rapid Communications in Mass Spectrometry, 11, 907–913.
   PubMed Web of Science ®Google Scholar
• Sottas, P. E., Robinson, N., Rabin, O., & Saugy, M. (2011). The athlete biological passport. Clinical Chemistry, 57(7), 969–976.
   PubMed Web of Science ®Google Scholar
• Staub, A., Rudaz, S., Saugy, M., Veuthey, J. L., & Schappler, J. (2010). Analysis of hemoglobin-based oxygen carriers by CE-UV/Vis and CE-ESI-TOF/MS. Electrophoresis, 31(7), 1241–1247.
   PubMed Web of Science ®Google Scholar
• Stübiger, G., Marchetti, M., Nagano, M., Reichel, C., Gmeiner, G., & Allmaier, G. (2005). Characterisation of intact recombinant human erythropoietins applied in doping by means of planar gel electrophoretic techniques and matrix-assisted laser desorption/ionisation linear time-of-flight mass spectrometry. Rapid Communication in Mass Spectrometry, 19(5), 728–742.
   PubMed Web of Science ®Google Scholar
• Sottas, P. E., Robinson, N., & Saugy, M. (2010). The athlete's biological passport and indirect markers of blood doping. In: D. Thieme, & P. Hemmersbach, (Eds.), (Doping in sports (pp. 305–326). Heidelberg: Springer.
   Google Scholar
• Thevis, M., Maurer, J., Kohler, M., Geyer, H., & Schänzer, W. (2007). Proteases in doping control analysis. International Journal of Sports Medicine, 28, 545–549.
   PubMed Web of Science ®Google Scholar
• Trent, R. J., & Alexander, I. E. (2005). Gene therapy in sport. British Journal of Sports Medicine, 40, 4–5.
   Web of Science ®Google Scholar
• Tsitsimpikou, C., Kouretas, D., Tsarouhas, K., Fitch, K., Spandidos, D. A., & Tsatsakis, A. (2011). Applications and biomonitoring issues of recombinant erythropoietins for doping control. Therapeutic Drug Monitoring, 33(1), 3–13.
   PubMed Web of Science ®Google Scholar
• United States Anti-Doping Agency (USADA). (2012). Statement From USADA CEO Travis T. Tygart Regarding The U. S. Postal Service Pro Cycling Team Doping Conspiracy, 2012. Retrieved January 28 2013 from http://www. usantidoping.org/default.asp?uid=4035
   Google Scholar
• Valeri, C. R., & Ragno, G. (2008). Testing for recombinant human erythropoietin. Journal of Applied Physiology, 105(6), 1993, author repply 1997–1998.
   PubMed Web of Science ®Google Scholar
• Voss, S., Lüdke, A., Romberg, S., Schänzer, E., Flenker, U., deMarees, M., … Schänzer, W. (2010). Effects of high intensity exercise on isoelectric profiles and SDS-PAGE mobility of erythropoietin. International Journal of Sports Medicine, 31, 367–371.
   PubMed Web of Science ®Google Scholar
• World Anti-Doping Agency –WADA (2013a) Harmonization of analysis and reporting of recombinant erythropoietins (i.e. epoetins) and analogues (e.g., darbepoetin, pegserpoetin, peginesatide, epo-fc) by electrophoretic techniques, Montreal. Retrieved 30 January 2013 from http://www.wada-ama. org/Documents/World_Anti-Doping_Program/WADP-IS-Labor atories/Technical_Documents/WADA-TD2013EPO-Harmoniz ation-Analysis-of-Recombinant-Erythropoietins-EN.pdf.
   Google Scholar
• World Anti-Doping Agency –WADA (2013b). The World Anti- Doping Code. The 2013 Prohibited List: International Standard. Retrieved January 19, 2013 from http://www.wada-ama.org/ Documents/World_Anti-Doping_Program/WADP-Prohibited-list/2013/WADA-Prohibited-List-2013-EN.pdf
   Google Scholar
• Xuereb, F., Chaignepain, S., Breilh, D., Godde, F., Saux, M. C., Lenz, C., Glueckmann, M., … Schmitter, J. M. (2011). Quantitative analysis of erythropoietin in human plasma by tandem mass spectrometry. Analytical and Bioanalytical Chemistry, 400(7), 2073–2084.
   PubMed Web of Science ®Google Scholar
• Yu, N. H., Ho, E. N., Wan, T. S., & Wong, A. S. (2010). Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta in equine plasma by nano-liquid chromatography-tandem mass spectrometry. Analytical and Bioanalytical Chemistry, 396, 2513–2521.
   PubMed Web of Science ®Google Scholar
• Zhou, G. H., Luo, G. A., Zhou, Y., Zhou, K. Y., Zhang, X. D., & Huang, L. Q. (1998). Application of capillary electrophoresis, liquid chromatography, electrospray–mass spectrometry and matrix-assisted laser desorption/ionization–time of flight–mass spectrometry to the characterization of recombinant human erythropoietin. Electrophoresis, 19(13), 2348–2355.
   PubMed Web of Science ®Google Scholar